Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-893-9 | CAS number: 75-71-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 1 656.6 mg/m³
- Most sensitive endpoint:
- carcinogenicity
- Route of original study:
- By inhalation
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 5
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 8 283.2 mg/m³
- Explanation for the modification of the dose descriptor starting point:
- Inhalation to inhalation
- AF for dose response relationship:
- 1
- Justification:
- NOAEC available
- AF for differences in duration of exposure:
- 1
- Justification:
- Chronic to chronic
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- No allometric scaling per REACH R.8.4.3.1 (inhalation)
- AF for other interspecies differences:
- 1
- Justification:
- Mechanistic and comparative metabolism data show that humans likely to be less sensitive to the effects of CFC-12 than rats and mice and are unlikely to be more sensitive.
- AF for intraspecies differences:
- 5
- Justification:
- A default assesment factor for workers, as proposed in the REACH Guidance (R 8.4.3.1)
- AF for the quality of the whole database:
- 1
- Justification:
- General assignment, long term studies available.
- AF for remaining uncertainties:
- 1
- Justification:
- Route to route extrapolation; Inhalation to inhalation
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Acute/short term exposure
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Acute/short term exposure
DNEL related information
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Additional information - workers
Workers
According to the REACH "Guidance on information requirements and chemical safety assessment" , a leading DN(M)EL needs to be derived for every relevant human population and every relevant route, duration and frequency of exposure, if feasible. As the substance is a gas, oral and dermal routes of exposure are considered to be irrelevant, therefore no DNELs were derived for these routes. The substance is not classified for acute toxicity, and according to REACH "Guidance on information requirements and chemical safety assessment" (R.8.4.3.1), no acute/short term exposure DNELs need to be derived.
A NOAEC can be derived for carcinogenic effects in the 2 year study in rats and mice since no effects were observed in the study. A DNEL for CFC-12 can be derived using the NOAEC:5000 ppm = 2.4726e+4 mg/m3 in the rat as the starting point and using the default approach proposed in the ECHA Guidance.
Calculation of DNEL for long-term exposure - carcinogenic / systemic effects in workers is derived as follows:
Description | Value | Remark |
Relevant dose descriptor | Corrected NOAEC 8283.2 mg/m3 (1675.0 ppm) | NOAEC:5000 ppm = 2.4726e+4 mg/m3 Correct for respiratory volume (from resting rat to active human): 6.7 m3/10m3 = 0.67. Correct for exposure time (from 4 hour rat to 8 hour human): 4/8 = 0.5 Corrected NOAEC =2.4726e+4 x 0.67 x 0.5 = 8283.2 mg/m3 (1675.0 ppm) |
Route to route extrapolation | 1 | Inhalation to inhalation |
Scaling factor animal to man | 1 | No allometric scaling per REACH R.8.4.3.1 (inhalation) |
Other interspecies differences | 1 | Mechanistic and comparative metabolism data show that humans likely to be less sensitive to the effects of CFC-12 than rats and mice and are unlikely to be more sensitive. |
Intraspecies variability | 5 | A default assesment factor for workers, as proposed in the REACH Guidance (R 8.4.3.1) |
Exposure duration | 1 | Chronic to chronic |
Dose response | 1 | NOAEL available |
Quality of the database | 1 | General assignment, long term studies available. |
DNEL | Value | |
For workers | 8283.2 / (1 x 1 x 1 x 5 x 1 x 1 x 1) =1656.6 mg/m3 = 334.97 ppm |
The worker DNEL value derived for chronic exposure would have to be adapted in case of a different shift system (= daily exposure time). In that case the amended DNEL would result in virtually the same value under the condition that the weekly exposure time would be almost identical.
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 420.34 mg/m³
- Most sensitive endpoint:
- carcinogenicity
- Route of original study:
- By inhalation
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 10
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 4 203.42 mg/m³
- Explanation for the modification of the dose descriptor starting point:
- Inhalation to inhalation.
- AF for dose response relationship:
- 1
- Justification:
- NOAEC available
- AF for differences in duration of exposure:
- 1
- Justification:
- Chronic to chronic
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- No allometric scaling per REACH R.8.4.3.1 (inhalation)
- AF for other interspecies differences:
- 1
- Justification:
- Mechanistic and comparative metabolism studies show that humans likely to be less sensitive to the effects of CFC-12 than rats and mice and are unlikely to be more sensitive.
- AF for intraspecies differences:
- 10
- Justification:
- A default assesment factor for the general population, as proposed in the REACH Guidance (R 8.4.3.1)
- AF for the quality of the whole database:
- 1
- Justification:
- General assignment, long term studies available.
- AF for remaining uncertainties:
- 1
- Justification:
- Route to route extrapolation; Inhalation to inhalation
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Acute/short term exposure
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Acute/short term exposure
DNEL related information
General Population - Hazard via oral route
Systemic effects
Acute/short term exposure
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - General Population
General population
According to the REACH "Guidance on information requirements and chemical safety assessment" , a leading DN(M)EL needs to be derived for every relevant human population and every relevant route, duration and frequency of exposure, if feasible. As the substance is a gas, oral and dermal routes of exposure are considered to be irrelevant, therefore no DNELs were derived for these routes. The substance is not classified for acute toxicity, and according to REACH "Guidance on information requirements and chemical safety assessment" (R.8.4.3.1), no acute/short term exposure DNELs need to be derived.
It should be noted that CFC-12 is not available to the general population, due to its ban in accordance with the Montreal Protocol. It is no longer used as a propellant in aerosols, and hence exposure is not relevant. However, this data is included for completeness purposes.
A NOAEC can be derived for carcinogenic effects in the 2 year study in rats and mice since no effects were observed in the study. A DNEL for CFC-12 can be derived using the NOAEC:5000 ppm = 2.4726e+4 mg/m3 in the rat as the starting point and using the default approach proposed in the ECHA Guidance.
Calculation of DNEL for long-term exposure - carcinogenic / systemic effects in the general population is derived as follows:
Description | Value | Remark |
Relevant dose descriptor | Corrected NOAEC 4203.42 mg/m3 (850 ppm) | NOAEC:5000 ppm = 2.4726e+4 mg/m3 Correct for exposure time (from 4 hour rat to 24 hour human): 4/24 = 0.17.(ECHA Guidance Chapter R.8 (fig. R.8-2)). Corrected LOAEL =2.4726e+4x 0.17 = 4203.42 mg/m3 (850 ppm) |
Route to route extrapolation | 1 | Inhalation to inhalation |
Scaling factor animal to man | 1 | No allometric scaling per REACH R.8.4.3.1 (inhalation) |
Other interspecies differences | 1 | Mechanistic and comparative metabolism studies show Mechanistic and comparative metabolism studies show that humans likely to be less sensitive to the effects of CFC-12 than rats and mice and are unlikely to be more sensitive. |
Intraspecies variability | 10 | A default assessment factor for the general population, as proposed in the REACH Guidance (R 8.4.3.1) |
Exposure duration | 1 | Chronic to chronic |
Dose response | 1 | NOAEL available |
Quality of the database | 1 | General assignment, long term studies available. |
DNEL | Value | |
For general population | 4203.42/ (1 x 1 x 1 x 10 x 1 x 1 x 1) =420.34 mg/m3 = 84.90 ppm |
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

Route: .live2